Menarini is among the leading pharmaceutical companies to have taken advantage of the European decentralised registration procedure. It was able to quickly and simultaneously register 5 products in 15 EU member states.
Our main focus is providing reimbursable medicinal products for the following areas of indication: cardiology, diabetology, rheumatology, infectiology, allergology and urology. RELIFE takes a holistic approach to aesthetic medicine, with products and effective techniques that address different clinician needs: REboost and REstore with HA injectables, REshape with absorbable reshaping sutures, REsurface with a peeling programme.
(This domain has limited access for health professionals only)
Quality: point of departure and arrival for our drugs.
READ MORE »
The Menarini Group has companies located almost all over the world.
We are looking for talented people. Discover the opportunities!!
10 core values have influenced the progress of our group.
READ MORE »
A. Menarini GmbH Thurgauerstr. 36/38 8050 Zürich
Opening hours Monday to Friday 09.00 - 12.00 h 13.00 - 16.00 h
Pharmacovigilance: what does it mean to monitor medicines?
Menarini continues to monitor the safety of a medicinal product after it has been launched on the market, from the moment it is prescribed by a doctor until it is used by the patient (and even afterwards). This monitoring is done through an important tool, pharmacovigilance, which takes care of identifying, evaluating, understanding and preventing any kind of safety issues that may arise after the use of a medicine. For all medicines marketed by Menarini worldwide, all possible information about problems arising from the use of a medicine and identified as possible adverse events is collected through safety reports.